Tumor necrosis factor and immunopathology.
Piguet
P F
PF
Department of Pathology, University of Geneva, CMU, Switzerland.
Grau
G E
GE
Vassalli
P
P
D001327:Autoimmune Diseases / Q000276:immunology*; D001761:Bleomycin / Q000009:adverse effects; D003095:Collagen Diseases / Q000276:immunology / Q000503:physiopathology; D003602:Cytotoxicity, Immunologic; D003877:Dermatitis, Contact / Q000276:immunology / Q000503:physiopathology; D006086:Graft vs Host Disease / Q000276:immunology; D007111:Immunity, Cellular; D007371:Interferon-gamma / Q000502:physiology; D007378:Interleukins / Q000502:physiology; D008288:Malaria / Q000276:immunology; D008407:Mast Cells / Q000276:immunology; D009164:Mycobacterium Infections / Q000276:immunology; D012829:Silicosis / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology / Q000378:metabolism / Q000502:physiology*
D007378:Interleukins; D014409:Tumor Necrosis Factor-alpha; D001761:Bleomycin; D007371:Interferon-gamma